J&J CEO Choice Likely Will Not Raise Consumer Business Profile
This article was originally published in The Tan Sheet
Executive Summary
Alex Gorsky will replace William Weldon as Johnson & Johnson CEO in April. Like his predecessor, who has led during a time of extensive OTC recalls, Gorsky’s experience with J&J comprises management of Rx pharmaceutical and medical device businesses, with no consumer background.
You may also be interested in...
Sanofi Should Take Note: As CEO Picks, Insiders Have History On Their Side
As Sanofi looks for a replacement for Chris Viehbacher, it might want to take the recent track records of the CEOs at its competitors into consideration before making a decision.
Sanofi Should Take Note: As CEO Picks, Insiders Have History On Their Side
As Sanofi looks for a replacement for Chris Viehbacher, it might want to take the recent track records of the CEOs at its competitors into consideration before making a decision.
People In Brief
Sklamberg heads CDER compliance; LoGalbo to lead Reckitt North America; Tris appoints business development VP; Antriasian VP at Life Extension; Personal Care Products Council promotes Powers; McNally directs Leedy’s new office; more People In Brief.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: